TWST Financials
Twist Bioscience Corp - Financial statements & key metrics
Stock Price
$132.07
Market Cap
$5.16B
P/E Ratio
-101.6
EPS
$-1.30
Income Statement Highlights
Most Recent Quarter: 2025-09-30
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-77.67M
EPS (Diluted)
$-1.30
Balance Sheet Highlights
Total Assets
$641.86M
Total Liabilities
$168.90M
Shareholders Equity
-
Cash & Equivalents
$183.05M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-47.63M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Net Margin
-19.8%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is TWST revenue?
View TWST's income statement for detailed revenue data.
Is TWST profitable?
TWST reported a loss of $77.67M in the most recent quarter. The net profit margin is -19.8%.
What is TWST market cap?
TWST has a market capitalization of $5.16B, making it a mid-cap stock.
Does TWST have debt?
View TWST's balance sheet for debt information.
What is TWST cash flow?
Cash flow data is available in the full financial statements.